Diabetes increases the risk of development of AF and s the one of the most common comorbidities in patients with AF.
The Framingham study reported that male and female diabetic patients are four and six times, respectively, more likely to develop atrial fibrillation then nion diabetic patients.
Increasing levels of hemoglobin A-1 C and duration of diabetes increase the risk of thromboembolism.
Diabetes is an independent risk factor for stroke and patients with diabetes have increased mortality compared with non-diabetic Patients. Other risk factors for stroke and patience with age for fibrillation, such as renal failure and peripheral vascular disease, more probable prevalent in patients with diabetes.
The CHA2DS2-VASc Score taking diabetic history into consideration, which emphasize the importance of diabetes in atrial fibrillation management.
Diabetes is an important risk factor for disease progression and adverse outcomes in patients with AF, making patients with diabetes a high-risk sub group.
Because of the risk of increased stroke/systemic embolism in patients with diabetes, oral anticoagulants are recommended for patients with atrial fibrillation and concomitant diabetes.